FDA
approval
· 2022-11-04
FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Original Application (Viona Pharmaceuticals Inc)
Summary
The FDA approves an original application for a generic fixed-dose combination of bisoprolol fumarate and hydrochlorothiazide for hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE)